Interferon gamma runs interference on persistent COVID-19

COVID-19 represents a collection of disease endotypes stemming from infection with SARS-CoV-2 and thus requires precision medicine approaches to target specific viral variants and stages of illness. In this issue, van Laarhoven et al.(1) describe five immunocompromised patients with prolonged COVID-...

Descripción completa

Detalles Bibliográficos
Autores principales: Elliott, Eric Isaac, Wang, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Viewpoint
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8500527/
https://www.ncbi.nlm.nih.gov/pubmed/34661183
http://dx.doi.org/10.1016/j.medj.2021.09.004
_version_ 1784580469773303808
author Elliott, Eric Isaac
Wang, Andrew
author_facet Elliott, Eric Isaac
Wang, Andrew
author_sort Elliott, Eric Isaac
collection PubMed
description COVID-19 represents a collection of disease endotypes stemming from infection with SARS-CoV-2 and thus requires precision medicine approaches to target specific viral variants and stages of illness. In this issue, van Laarhoven et al.(1) describe five immunocompromised patients with prolonged COVID-19 successfully treated with interferon gamma (IFNγ).
format Online
Article
Text
id pubmed-8500527
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-85005272021-10-12 Interferon gamma runs interference on persistent COVID-19 Elliott, Eric Isaac Wang, Andrew Med (N Y) Viewpoint COVID-19 represents a collection of disease endotypes stemming from infection with SARS-CoV-2 and thus requires precision medicine approaches to target specific viral variants and stages of illness. In this issue, van Laarhoven et al.(1) describe five immunocompromised patients with prolonged COVID-19 successfully treated with interferon gamma (IFNγ). Elsevier Inc. 2021-10-08 2021-10-08 /pmc/articles/PMC8500527/ /pubmed/34661183 http://dx.doi.org/10.1016/j.medj.2021.09.004 Text en © 2021 Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Viewpoint
Elliott, Eric Isaac
Wang, Andrew
Interferon gamma runs interference on persistent COVID-19
title Interferon gamma runs interference on persistent COVID-19
title_full Interferon gamma runs interference on persistent COVID-19
title_fullStr Interferon gamma runs interference on persistent COVID-19
title_full_unstemmed Interferon gamma runs interference on persistent COVID-19
title_short Interferon gamma runs interference on persistent COVID-19
title_sort interferon gamma runs interference on persistent covid-19
topic Viewpoint
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8500527/
https://www.ncbi.nlm.nih.gov/pubmed/34661183
http://dx.doi.org/10.1016/j.medj.2021.09.004
work_keys_str_mv AT elliottericisaac interferongammarunsinterferenceonpersistentcovid19
AT wangandrew interferongammarunsinterferenceonpersistentcovid19

Ejemplares similares